Article

Using Healthcare Claims Data to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial Hypercholesterolemia

2024-07-29

Abstract excerpt

<h4>Background</h4> Individuals with familial hypercholesterolemia (FH) require intensive lipid-lowering therapy, starting with high-intensity statins and adding ezetimibe and PCSK9 inhibitors (PCSK9i) as needed to reach target LDL-C levels. There are limited data on disparities in the use of these therapies among individuals with FH in the US. <h4>Methods</h4> We queried a large US healthcare claims repository co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7da9d0aa-869d-5742-b783-921390e9a9d0
DOI: 10.1101/2024.07.26.24311087

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Using Healthcare Claims Data to Identify Health Disparities for Individuals with Diagnosed and Undiagnosed Familial HypercholesterolemiaDOI 10.1101/2024.07.26.24311087Read

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.Semantic proximity Read

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.Semantic proximity Read

Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.Semantic proximity Read

Homozygous familial hypercholesterolemia (HoFH) in Canada.Semantic proximity Read

Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.Semantic proximity Read

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemiaSemantic proximity Read

Genetic identification of familial hypercholesterolemia within a single U.S. health care systemSemantic proximity Read

Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million PatientsSemantic proximity Read

Systematic identification of familial hypercholesterolaemia: An updated systematic review and meta-analysis.Semantic proximity Read

Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Historical Cholesterol ExposureSemantic proximity Read

Management and Consequences of Genotype-Positive Familial Hypercholesterolemia.Semantic proximity Read

Designing to Implement Genomics Informed ASCVD Risk Assessment: Patient and Clinician Perspectives about Identifying and Managing the Underlying Causes of Severe HypercholesterolemiaSemantic proximity Read